{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:39:55Z","timestamp":1769222395577,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[1994,3]]},"DOI":"10.1007\/bf03164982","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T08:23:55Z","timestamp":1254299035000},"page":"17-22","source":"Crossref","is-referenced-by-count":3,"title":["11C-labeled 2\u2032-iododiazepam for PET studies of benzodiazepine receptors: Synthesis and comparison of biodistribution with its radioiodinated compound"],"prefix":"10.1007","volume":"8","author":[{"given":"Yasuhiko","family":"Iida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Saji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Magata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwao","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yoshitake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03164982_CR1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(88)92468-3","volume":"II","author":"I Savic","year":"1988","unstructured":"Savic I, Roland P, Sedvall G, Persson A, Pauli S, Widen L.In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci.Lancet II: 863\u2013866, 1988.","journal-title":"Lancet"},{"key":"BF03164982_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00950756","volume":"18","author":"P Bartenstein","year":"1991","unstructured":"Bartenstein P, Ludolph A, Schober O, Lottes G, Scheidhauer K, Sciuk J, et al. Benzodiazepine receptors and cerebral blood flow in partial epilepsy.Eur J Nucl Med 18: 111\u2013118, 1991.","journal-title":"Eur J Nucl Med"},{"key":"BF03164982_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410180207","volume":"18","author":"PJ Whitehouse","year":"1985","unstructured":"Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, et al. Neurotransmitter receptor alterations in Huntington\u2019s disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.Ann Neurol 18: 202\u2013210, 1985.","journal-title":"Ann Neurol"},{"key":"BF03164982_CR4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/WNL.37.6.916","volume":"37","author":"RR Trifiletti","year":"1987","unstructured":"Trifiletti RR, Snowman AM, Whitehouse PJ, Marcus KA, Snyder SH. Huntington\u2019s disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex.Neurology 37: 916\u2013922, 1987.","journal-title":"Neurology"},{"key":"BF03164982_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0006-8993(83)90276-7","volume":"278","author":"F Owen","year":"1983","unstructured":"Owen F, Poulter M, Waddington JL, Mashal RD, Crow TJ. [H-3]Ro 05-4864 and [H-3]flunitrazepam binding inkanate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of Alzheimer type.Brain Res 278: 373\u2013375, 1983.","journal-title":"Brain Res"},{"key":"BF03164982_CR6","first-page":"1593","volume":"27","author":"H Shinotoh","year":"1986","unstructured":"Shinotoh H, Yamasaki T, Inoue O, Itoh T, Suzuki K, Hashimoto K, et al. Visualization of specific binding sites of benzodiazepine in human brain.J Nucl Med 27: 1593\u20131599, 1986.","journal-title":"J Nucl Med"},{"key":"BF03164982_CR7","first-page":"365","volume":"15","author":"K Ishiwata","year":"1988","unstructured":"Ishiwata K, Yanai K, Ido T, Miura-Kanno Y, Kawashima K. Synthesis and biodistribution of [11C]fludiazepam for imaging benzodiazepine receptors.Nucl Med Biol 15: 365\u2013371, 1988.","journal-title":"Nucl Med Biol"},{"key":"BF03164982_CR8","first-page":"1007","volume":"31","author":"H-F Beer","year":"1990","unstructured":"Beer H-F, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al.In vitro andin vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 31: 1007\u20131014, 1990.","journal-title":"J Nucl Med"},{"key":"BF03164982_CR9","first-page":"109","volume-title":"Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes","author":"B Sadzot","year":"1990","unstructured":"Sadzot B, Frost JJ. Benzodiazepine receptors.In Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes, Frost JJ, Wagner Jr HN (eds.), New York, Raven Press, pp. 109\u2013127, 1990."},{"key":"BF03164982_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0883-2889(89)90199-8","volume":"40","author":"AA Wilson","year":"1989","unstructured":"Wilson AA, Dannals RF, Ravert HT, Wagner Jr HN. Preparation of [11C]- and [125I]IMB: a dopamine D-2 receptor antagonist.Appl Radiat Isot 40: 369\u2013373, 1989.","journal-title":"Appl Radiat Isot"},{"key":"BF03164982_CR11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0883-2889(92)90039-H","volume":"43","author":"ME Dort Van","year":"1992","unstructured":"Van Dort ME, Kilbourn MR, Chakraborty PK, Richfield EK, Gildersleeve DL, Wieland DM. Iodine-125 and fiuorine- 18 labeled aryl-1,4-dialkylpiperazines: potential radiopharmaceuticals forin vivo study of the dopamine uptake system.Appl Radiat Isot 43: 671\u2013680, 1992.","journal-title":"Appl Radiat Isot"},{"key":"BF03164982_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/syn.890120309","volume":"12","author":"DF Wong","year":"1992","unstructured":"Wong DF, Wilson AA, Chen C, Minkin E, Dannals RF, Ravert HT, et al.In-vivo studies of [I-125]idodbenzamide and [C-11]iodobenzamide\u2014a ligand suitable for positron emission tomography and single photon emission tomography imaging of cerebral D(2)-dopamine receptors.Synapse 12: 236\u2013241, 1992.","journal-title":"Synapse"},{"key":"BF03164982_CR13","first-page":"655","volume":"26","author":"MR Kilbourn","year":"1985","unstructured":"Kilbourn MR, Zalutsky MR. Research and clinical potential of receptor based radiophannaceuticals.J Nucl Med 26: 655\u2013662, 1985.","journal-title":"J Nucl Med"},{"key":"BF03164982_CR14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1471-4159.1985.tb12891.x","volume":"44","author":"CD Arnett","year":"1985","unstructured":"Arnett CD, Shiue CY, Wolf AP, Fowler JS, Logan J, Watanabe M. Comparison of three18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.J Neurochem 44: 835\u2013844, 1985.","journal-title":"J Neurochem"},{"key":"BF03164982_CR15","first-page":"85","volume":"17","author":"HF Kung","year":"1990","unstructured":"Kung HF. Radiopharmaceuticals for CNS receptor imaging with SPECT.Nucl Med Biol 17: 85\u201392, 1990.","journal-title":"Nucl Med Biol"},{"key":"BF03164982_CR16","first-page":"193","volume":"178","author":"E Kleijn Van Der","year":"1969","unstructured":"Van Der Kleijn E. Kinetics of distribution and metabolism of diazepam and chlordiazepoxide in mice.Arch Int Pharmacodyn 178: 193\u2013215, 1969.","journal-title":"Arch Int Pharmacodyn"},{"key":"BF03164982_CR17","first-page":"237","volume-title":"Drugs Affecting The Central Nervous System, Volume 2","author":"LH Sternbach","year":"1968","unstructured":"Sternbach LH, Randall LO, Banziger R, Lehr H. Structureactivity relationships in the 1,4-benzodiazepine series.In Drugs Affecting The Central Nervous System, Volume 2, Burger A (ed.), New York, Mercel Dekker Inc., pp. 237\u2013264, 1968."},{"key":"BF03164982_CR18","first-page":"1073","volume":"34","author":"PA Boera","year":"1979","unstructured":"Boera PA, Gilli G, Bertolasi V. Application of the Free-Wilson model to the analysis of three different pharmacological activity tests in benzodiazepines.Farmaco-Ed Sc 34: 1073\u20131082, 1979.","journal-title":"Farmaco-Ed Sc"},{"key":"BF03164982_CR19","first-page":"165","volume-title":"Advances in Drug Research, Volume 14","author":"W Haefely","year":"1985","unstructured":"Haefely W, Kyburz E, Gerecke M, Mohler H. Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists.In Advances in Drug Research, Volume 14, Testa B (ed.), London, Academic Press Inc., pp. 165\u2013322, 1985."},{"key":"BF03164982_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jmr.300050205","volume":"5","author":"SP Gupta","year":"1992","unstructured":"Gupta SP, Saha RN, Muichandani V. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: recognition of active sites in receptor and modelling of interaction.J Mol Recognit 5: 75\u201380, 1992.","journal-title":"J Mol Recognit"},{"key":"BF03164982_CR21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1248\/bpb.16.513","volume":"16","author":"H Saji","year":"1993","unstructured":"Saji H, Iida Y, Ariyoshi K, Nakatsuka I, Kataoka M, Yoshitake A, et al. An approach for benzodiazepine receptor binding assay with radioiodinated ligand:125I-labeled diazepam derivative.Biol Pharm Bull 16: 513\u2013515, 1993.","journal-title":"Biol Pharm Bull"},{"key":"BF03164982_CR22","first-page":"932","volume":"34","author":"H Saji","year":"1993","unstructured":"Saji H, Iida Y, Nakatsuka I, Kataoka M, Ariyoshi K, Magata Y, et al. Radioiodinated 2\u2019-iododiazepam: apotential imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 34: 932\u2013937, 1993.","journal-title":"J Nucl Med"},{"key":"BF03164982_CR23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1248\/cpb.40.734","volume":"40","author":"H Saji","year":"1992","unstructured":"Saji H, Magata Y, Yamada Y, Tajima K, Yomekura Y, Konishi J, et al. Synthesis of (S)-N-[methyl-11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography.Chem Pharm Bull 40: 734\u2013736, 1992.","journal-title":"Chem Pharm Bull"},{"key":"BF03164982_CR24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1471-4159.1966.tb09873.x","volume":"13","author":"J Glowinski","year":"1966","unstructured":"Glowinski J, Iversen L. Regional studies of catecholamines in the rat brain-I: the disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions on the brain.J Neurochem 13: 655\u2013669, 1966.","journal-title":"J Neurochem"},{"key":"BF03164982_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(81)90340-X","volume":"75","author":"D Comar","year":"1981","unstructured":"Comar D, Maziere M, Cepeda C, Godot J-M, Menini C, Naquet R. The kinetics and displacement of [11C]flunitrazepam in the brain of the living baboon.Eur J Pharmacol 75: 21\u201326, 1981.","journal-title":"Eur J Pharmacol"},{"key":"BF03164982_CR26","first-page":"173","volume-title":"The Bezodiazepines: From Molecular Biology to Clinical Practice","author":"SA Kaplan","year":"1983","unstructured":"Kaplan SA, Jack ML. Metabolism of the benzodiazepines: pharmacokinetic and pharmacodynamic considerations.In The Bezodiazepines: From Molecular Biology to Clinical Practice, Costa E (ed.), New York, Raven Press, pp. 173\u2013199, 1983."},{"key":"BF03164982_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0090-9556(25)07073-4","volume":"19","author":"X Xie","year":"1991","unstructured":"Xie X, Steiner H, Bickel MH. Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure.Drug Metab Disposition 19: 15\u201319, 1991.","journal-title":"Drug Metab Disposition"},{"key":"BF03164982_CR28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3565(25)23072-5","volume":"256","author":"E Richelson","year":"1991","unstructured":"Richelson E, Nelson A, Neeper R. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortexin vitro.J Pharmacol Exp Ther 256: 897\u2013901, 1991.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03164982_CR29","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/0006-2952(68)90134-2","volume":"17","author":"MA Schwartz","year":"1968","unstructured":"Schwartz MA, Postma E. Metabolism of diazepamin vitro.Biochem Pharmacol 17: 2443\u20132449, 1968.","journal-title":"Biochem Pharmacol"},{"key":"BF03164982_CR30","first-page":"340","volume":"32","author":"H Saji","year":"1993","unstructured":"Saji H, Iida Y, Nakatsuka I, Kataoka M, Yoshitake A, Yokoyama A. Evaluation of radioiodinated desmethyl diazepam as radiotracer forin vivo quantitative studies of benzodiazepine receptors.J Labelled Compd Radiopharm 32: 340\u2013341, 1993.","journal-title":"J Labelled Compd Radiopharm"},{"key":"BF03164982_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0028-3908(84)90064-9","volume":"23","author":"JG Richard","year":"1984","unstructured":"Richard JG, Mohler H. Benzodiazepine receptors.Neuropharmacology 23: 233\u2013242, 1984.","journal-title":"Neuropharmacology"},{"key":"BF03164982_CR32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(85)90218-3","volume":"110","author":"Y Samson","year":"1985","unstructured":"Samson Y. Hantraye P, Baron JC, Soussaline F, Comar D, Maziere M. Kinetics and displacement of [C-11]Ro 15-1788, a benzodiazepine antagonist, studies in human brainin vivo by positron tomography.Eur J Pharmacol 110: 247\u2013251, 1985.","journal-title":"Eur J Pharmacol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03164982.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03164982\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03164982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:42:22Z","timestamp":1739364142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03164982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["BF03164982"],"URL":"https:\/\/doi.org\/10.1007\/bf03164982","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}